| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Heron Therapeutics, Inc. /de/ (HRTX) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. HRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 30.05M | $28.20M | - | |
| CEO | 662.1K | $621.4K | - | |
| CFO | 215.9K | $202.6K | - | |
| COO | 188.3K | $176.8K | - | |
| Dir | 123.7K | $116.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Johnson Craig A79 | Director | Sell | 250 | $12.30 | $3,074.10 | -7.5% | -20.3% | -64.7% | |
| Sep 21, 2021 | Christian Waage75 | Director | Sell | 300 | $12.31 | $3,691.95 | -7.9% | -20.3% | -64.7% | |
| Jun 21, 2021 | Christian Waage75 | Director | Sell | 300 | $15.20 | $4,559.19 | -7.3% | -21.1% | -81.2% | |
| Jun 21, 2021 | Johnson Craig A79 | Director | Sell | 250 | $15.20 | $3,800.60 | -7.0% | -21.1% | -81.2% | |
| May 3, 2021 | Manhard Kimberly80 | EVP, Drug Development | Sell | 1,529 | $17.66 | $27,008.71 | -48.3% | -28.8% | -72.6% | |
| Apr 15, 2021 | Christian Waage75 | Director | Sell | 300 | $17.51 | $5,253.78 | -6.8% | -26.7% | -66.9% | |
| Apr 6, 2021 | Johnson Craig A79 | Director | Sell | 250 | $17.22 | $4,305.20 | -6.5% | -14.0% | -62.5% | |
| Jan 14, 2021 | Szekeres David Leslie | EVP, Chief Operating Officer | Sale+OE | 827 | $18.09 | $14,960.18 | -100% | - | - | |
| Jan 8, 2021 | Szekeres David Leslie | EVP, Chief Operating Officer | Sell | 3,571 | $19.66 | $70,219.43 | -100% | - | - | |
| Dec 22, 2020 | Manhard Kimberly80 | EVP, Drug Development | Sale+OE | 10,000 | $20.00 | $200,000.00 | -100% | - | - |